Polio Vaccine & Cancer Clinical Trials

• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Diphtheria, Tetanus & Pertussis Vaccine (DTaP) Vaccine & a Haemophilus Influenza Type B (Hib) Vaccine in Healthy Children 15 m of Age
  ClinicalTrials.gov Identifier: NCT00197236 - Active, not recruiting
  Hepatitis A
  
• Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00013871 - Active, not recruiting
  HIV Infections; Hepatitis B; Measles; Pneumococcal Infections; Pertussis
  
• Immunogenicity and Safety of PENTAXIM™ in Indian Population
  ClinicalTrials.gov Identifier: NCT00259337 - Active, not recruiting
  Diphtheria; Tetanus; Polio; Pertussis; Haemophilus Influenzae Type B
  
• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Measles/Mumps/Rubella Vaccine & a Varicella (Chickenpox) Vaccine in Healthy Children
  ClinicalTrials.gov Identifier: NCT00197015 - Recruiting
  Hepatitis A
  
• Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination
  ClinicalTrials.gov Identifier: NCT00291954 - Active, not recruiting
  Hepatitis B Infection
  
• Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children with Weakened Immune Systems
  ClinicalTrials.gov Identifier: NCT00006066 - Active, not recruiting
  HIV Infections
  
• Pentavalent DTaP-Hep B-IPV
  ClinicalTrials.gov Identifier: NCT00133445 - Active, not recruiting
  Pertussis; Hepatitis B; Polio
  
• Primary & Booster Study in Infants to Demonstrate Non-Inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine.
  ClinicalTrials.gov Identifier: NCT00327184 - Active, not recruiting
  H.Influenzae Type b Disease; Meningococcal Serogroup C Diseases
  
• Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
  ClinicalTrials.gov Identifier: NCT00582647 - Recruiting
  Esophageal Cancer; Bile Duct Neoplasms; Gastric Cancer; Liver Cancer; Melanoma; Pancreatic Cancer; Sarcoma
  
• COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & AOM Efficacy Study of the Pneumococcal Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00466947 - Recruiting
  Pneumonia & AOM Caused by S. Pneumoniae & H. Influenzae
  
• Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine
  ClinicalTrials.gov Identifier: NCT00343889 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Infections
  
• Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00325156 - Active, not recruiting
  Infant; Healthy
  
• Long Term Follow-up Studies at Yrs 2,3,4 & 5, Where 2 Formulations of the Combined Hepatitis A & B Vaccine Was Compared
  ClinicalTrials.gov Identifier: NCT00197184 - Active, not recruiting
  Hepatitis A; Hepatitis B
  
• Evaluate the Effect of Several Risk Factors That Are Likely to Influence the Immunogenicity of Combined Hepatitis A & B Vaccine vs Monovalent Hepatitis A & Hepatitis B Vaccines
  ClinicalTrials.gov Identifier: NCT00289731 - Active, not recruiting
  Hepatitis A; Hepatitis B
  
• Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)
  ClinicalTrials.gov Identifier: NCT00478621 - Active, not recruiting
  HPV Infections; Cervical Neoplasia
  
• Safety & Immunogenicity of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 Months of Age.
  ClinicalTrials.gov Identifier: NCT00345579 - Active, not recruiting
  Haemophilus Infections; Meningococcal Infections
  
• A Dose-Escalation Vaccine Trial In HER2-Overexpressing Patients With High-Risk Breast Cancer
  ClinicalTrials.gov Identifier: NCT00058526 - Active, not recruiting
  Breast Cancer
  
• Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
  ClinicalTrials.gov Identifier: NCT00030823 - Active, not recruiting
  Breast Cancer; Male Breast Cancer
  
• Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003761 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Immunotherapy in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003432 - Active, not recruiting
  stage IV breast cancer
  
• Vaccine Therapy in Preventing Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
  ClinicalTrials.gov Identifier: NCT00128661 - Active, not recruiting
  Cervical Cancer; high-grade squamous intraepithelial lesion
  
• Treating High Risk Leukemia with CD40 Ligand & IL-2 Gene Modified Tumor Vaccine.
  ClinicalTrials.gov Identifier: NCT00058799 - Active, not recruiting
  Leukemia
  
• Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00002475 - Active, not recruiting
  Breast Cancer; Colorectal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer; pleura cancer
  
• Evaluation of a New Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Lost Antibody After Previous Hepatitis B Vaccination.
  ClinicalTrials.gov Identifier: NCT00291980 - Active, not recruiting
  Hepatitis B
  
• Lg Term F-U Studies Yrs 16-20 After Vaccine Dose of Hepatitis B Vaccine in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg)& Hepatitis B Surface Antigen (HBsAg)
  ClinicalTrials.gov Identifier: NCT00240500 - Active, not recruiting
  Hepatitis B
  
• GVAX® Prostate Cancer Vaccine vs Docetaxel and Prednisone in Patients with Metastatic Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00089856 - Active, not recruiting
  Prostate Cancer
  
• Immunogenicity of DTaP-IPV-HB-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule
  ClinicalTrials.gov Identifier: NCT00315055 - Active, not recruiting
  Hepatitis B; Polio; Diphtheria; Pertussis
  
• Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00088933 - Active, not recruiting
  Colon Cancer; Non-small cell lung cancer; Rectal Cancer; Small Cell Lung Cancer
  
• A Study to Test the Safety & Effectiveness of Docetaxel With RAD001 & Bevacizumab in Men With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00574769 - Recruiting
  Prostate Cancer
  
• Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00036933 - Active, not recruiting
  stage III prostate cancer; recurrent prostate cancer
  
• Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine
  ClinicalTrials.gov Identifier: NCT00137696 - Completed
  Poliomyelitis
  
• Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V
  ClinicalTrials.gov Identifier: NCT00097396 - Active, not recruiting
  Pneumonic Plague; Preventive therapy
  
• Human Papillomavirus (HPV) Vaccine Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine
  ClinicalTrials.gov Identifier: NCT00316693 - Active, not recruiting
  HPV-16/18 Infections; Cervical Neoplasia
  
• Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV
  ClinicalTrials.gov Identifier: NCT00348387 - Active, not recruiting
  Poliomyelitis; Imovax Polio
  
• Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016146 - Active, not recruiting
  recurrent prostate cancer
  
• Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®
  ClinicalTrials.gov Identifier: NCT00362427 - Active, not recruiting
  Diphtheria; Pertussis; Polio; Hepatitis B; Tetanus
  
• Vaccine Therapy Plus Biological Therapy in Treating Patients With Relapsed Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016120 - Active, not recruiting
  recurrent prostate cancer
  
• Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00007826 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants
  ClinicalTrials.gov Identifier: NCT00401531 - Active, not recruiting
  Hepatitis B; Polio; Diphtheria; Pertussis; Haemophilus Influenzae Type B
  
• Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter in Achival & Frozen Tissue Sample
  ClinicalTrials.gov Identifier: NCT00568438 - Recruiting
  Breast Cancer
  
• PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003871 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Comparison of DTaP IPV HB PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV
  ClinicalTrials.gov Identifier: NCT00362336 - Active, not recruiting
  Hepatitis B; Polio; Diphtheria; Pertussis; Haemophilus Influenzae Type B
  
• Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bios' HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs
  ClinicalTrials.gov Identifier: NCT00541970 - Recruiting
  Papillomavirus Infections; Cervical Cancer
  
• Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00091273 - Active, not recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK’s HRV Vaccine as 2-Dose Vaccination (Infants)
  ClinicalTrials.gov Identifier: NCT00363545 - Active, not recruiting
  Gastroenteritis
  
• Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00091286 - Recruiting
  Colon Cancer; Rectal Cancer
  
• Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00010127 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate
  
• Vaccine Therapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00005629 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
  
• Vaccine Therapy in Treating Patients With Liver Metastases From Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00103142 - Recruiting
  Colon Cancer; liver metastases; Rectal Cancer
  
• Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer
  ClinicalTrials.gov Identifier: NCT00176241 - Recruiting
  Head and Neck Cancer
  
• Study in Adolescents/Adults to Evaluate Non-Inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00356369 - Active, not recruiting
  Meningococcal Infections
  
• Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine
  ClinicalTrials.gov Identifier: NCT00325143 - Active, not recruiting
  Healthy; Infant
  
• Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00128622 - Recruiting
  adult solid tumor; Breast Cancer; Colorectal Cancer; Lung Cancer; Male Breast Cancer; Pancreatic Cancer
  
• Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00066729 - Active, not recruiting
  stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer; ...
  
• Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00020787 - Active, not recruiting
  stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
  
• Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Children .
  ClinicalTrials.gov Identifier: NCT00502593 - Active, not recruiting
  Influenza
  
• Vaccine Therapy in Treating Patients With Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00096629 - Active, not recruiting
  recurrent renal cell cancer; stage I renal cell cancer; stage II renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
  
• Assess Reacto- & Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule
  ClinicalTrials.gov Identifier: NCT00513409 - Active, not recruiting
  Diseases Caused by Streptococcus Pneumoniae or Haemophilus Influenzae
  
• Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
  ClinicalTrials.gov Identifier: NCT00033748 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; liver metastases
  
• Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age
  ClinicalTrials.gov Identifier: NCT00397215 - Active, not recruiting
  Influenza
  
• Clinical & Web-Based Diet & Activity Counseling for Men
  ClinicalTrials.gov Identifier: NCT00412633 - Active, not recruiting
  Obesity
  
• Vaccine Therapy in Treating Patients With Transitional Cell Cancer of the Bladder
  ClinicalTrials.gov Identifier: NCT00070070 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage I bladder cancer
  
• Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
  ClinicalTrials.gov Identifier: NCT00538213 - Active, not recruiting
  Influenza Infection
  
• Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
  ClinicalTrials.gov Identifier: NCT00538473 - Active, not recruiting
  Influenza Infection
  
• Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00093522 - Active, not recruiting
  recurrent renal cell cancer; Stage IV Renal Cell Cancer
  
• Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00023634 - Active, not recruiting
  adult brain tumor; Gastric Cancer; ovarian epithelial cancer; Prostate Cancer
  
• Evaluate the Safety & Immunogenicity of GSK Biologicals’ 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule
  ClinicalTrials.gov Identifier: NCT00307034 - Active, not recruiting
  Pneumococcal Infections
  
• Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older.
  ClinicalTrials.gov Identifier: NCT00294047 - Active, not recruiting
  Prophylaxis for HPV Infections & Assoc. Cervical Neoplasia
  
• Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003819 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer
  
• Vaccine Therapy in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003638 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00027833 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
  
• Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00152802 - Active, not recruiting
  transplant
  
• Dose-Ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers
  ClinicalTrials.gov Identifier: NCT00434512 - Active, not recruiting
  Acquired Immunodeficiency Syndrome
  
• Docetaxel With or Without Vaccine Therapy and GM-CSF in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00217750 - Recruiting
  Male Breast Cancer; recurrent breast cancer; stage IV breast cancer
  
• Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge
  ClinicalTrials.gov Identifier: NCT00411697 - Active, not recruiting
  Hepatitis B
  
• Vaccine Therapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00022334 - Active, not recruiting
  localized resectable adult primary liver cancer; localized unresectable adult primary liver cancer; advanced adult primary liver cancer; ...
  
• Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer
  ClinicalTrials.gov Identifier: NCT00017537 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage IV non-small cell lung cancer; unspecified adult solid tumor, protocol specific; ...
  
• Provenge® Immunotherapy Vaccine for the Treatment of Metastatic Prostate Cancer after Failing Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00065442 - Active, not recruiting
  Prostate Cancer
  
• Immuno & Safety Study of GSK Biologicals’ Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs
  ClinicalTrials.gov Identifier: NCT00343915 - Active, not recruiting
  Prophylaxis of Hepatitis B
  
• Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Adolescents
  ClinicalTrials.gov Identifier: NCT00387725 - Recruiting
  Healthy
  
• A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients
  ClinicalTrials.gov Identifier: NCT00219102 - Active, not recruiting
  Hypertension; Diabetes
  
• 24-Hour IOP & Blood Pressure Control in POAG & OHT Patients
  ClinicalTrials.gov Identifier: NCT00330577 - Active, not recruiting
  Primary Open Angle Glaucoma; Ocular Hypertension
  
• Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Mth Schedule in Healthy Children
  ClinicalTrials.gov Identifier: NCT00289744 - Active, not recruiting
  Hepatitis A; Hepatitis B
  
• Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00289770 - Active, not recruiting
  Hepatitis A; Hepatitis B
  
• Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00058435 - Active, not recruiting
  stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; ...
  
• Vaccine Therapy and Interleukin-2 in Treating Patients With Stage IV Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00031564 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00091403 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma
  
• Booster Vaccination Study to Assess Immune Response & Safety of a Dose of GSK Biologicals’ Mencevax™ ACWY at 24-30 Mths Age & to Assess Immune Response & Safety of 1/5th of a Dose of Mencevax™ ACWY at 30-36 Mths Age in Subjects Primed in
  ClinicalTrials.gov Identifier: NCT00291343 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• Docetaxel in Combination with GVAX ® Vaccine for Prostate Cancer Vs Docetaxel and Prednisone in Patients with Metastatic Hormone-Refractory Prostate Cancer With Pain
  ClinicalTrials.gov Identifier: NCT00133224 - Recruiting
  Prostate Cancer
  
• Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adult Subjects
  ClinicalTrials.gov Identifier: NCT00289718 - Active, not recruiting
  Hepatitis A; Hepatitis B
  
• Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00169455 - Completed
  Rotavirus Gastroenteritis
  
• Vaccine Therapy, MDX-010, and GM-CSF in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00124670 - Recruiting
  recurrent prostate cancer; stage IV prostate cancer
  
• Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00103116 - Active, not recruiting
  stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• Safety & Immunogenicity Study of a Prime Boost Concept of GSK Biologicals’ Pandemic Influenza Vaccine (GSK1119711A)
  ClinicalTrials.gov Identifier: NCT00430521 - Active, not recruiting
  Pandemic Influenza
  
• Vaccine Therapy Combined With Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer)
  ClinicalTrials.gov Identifier: NCT00085436 - Active, not recruiting
  recurrent renal cell cancer; Stage IV Renal Cell Cancer
  
• Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children.
  ClinicalTrials.gov Identifier: NCT00474266 - Active, not recruiting
  Meningococcal Serogroups A, C, W-135 and/or Y Disease; Measles; Mumps; Rubella; Varicella
  
• Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00023985 - Active, not recruiting
  stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer
  
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00009958 - Active, not recruiting
  unspecified adult solid tumor, protocol specific